Juno Therapeutics, Thermo Fisher ink partnership deal to manufacture CAR-T therapies
admin 21st December 2017 Uncategorised 0Juno Therapeutics, a biopharma focused on developing cellular immunotherapies to treat cancer, has inked a deal to use Thermo Fisher Scientific’s activation reagents in manufacturing its CAR-T therapies.
More: Juno Therapeutics, Thermo Fisher ink partnership deal to manufacture CAR-T therapies
Source: fierce